Parkinson’s Disease - Medical world has struggled in finding permanent cure for this condition that usually affects men over the age of 50 years, but now this maybe changing with the advent of ...

which indicates that MSCs might be a new strategy for the treatment of immune-mediated diseases. Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal stem cells that can be isolated ...

Bayer subsidiary BlueRock Therapeutics has dosed the first Parkinson's ... disease progresses. In the BlueRock trial, an unnamed patient has now been administered the first dose of pluripotent ...

CNS diseases are complex, resulting in loss of sensory, motor, and cognitive functions, as is the case in Parkinson’s disease (Davie ... (RPE). • Embryonic stem cells (ESCs) are pluripotent ...

Liver diseases are a major health concern globally, and are associated with poor survival and prognosis of patients. This creates the need for patients to accept the main alternative treatment ... ESC ...

Brain implants, made from small clusters of brain cells, could help restore neural pathways damaged by Parkinson’s disease.

Bayer subsidiary BlueRock Therapeutics has been granted a fast-track review by the FDA for DA01, its stem cell-based therapy for Parkinson's disease which is currently in early-stage clinical testing.

A compound that showed early promise in the treatment of Parkinson's disease in fruit flies has also shown neuroprotective ...

The only curative treatment currently available for people with the disease in the UK is a donor stem cell transplant, but it is not given to many patients because of the risks involved.

First Mouse With Two Male Parents to Reach Adulthood Jan. 28, 2025 — A team of stem cell scientists have successfully used embryonic stem cell engineering to create a bi-paternal mouse -- a ...